spacer
home > epc > winter 2003 > central laboratories and the importance of an effective quality system
PUBLICATIONS
European Pharmaceutical Contractor

Central Laboratories and the Importance of an Effective Quality System

Central laboratories play a significant role in the clinical trials process by providing drug development companies with clean, combinable laboratory data, which can be analysed and reported in a timely and cost-effective manner, and which can undergo global regulatory review. Due to the critical nature of the data being generated, it is essential that data are accurate, reliable and reproducible.

So, how can a central laboratory assure its clients of the quality of the data being generated in its operation? The answer lies in the question: the laboratory must establish a quality assurance system. Establishing a quality system involves the implementation of a series of processes and procedures that standardise operations. For a quality system to be credible, it must be examined by an independent external party that is recognised as being competent in the assessment of such a system. These external parties will investigate the laboratory's compliance to a recognised quality standard or guideline and make a recommendation for registration.

There are many different quality standards and guidelines in existence that are recognised in industry. For central laboratories, some quality standards are compulsory depending on the location of operations, whilst other standards are optional and may be adopted by laboratories wishing to enhance their reputation for quality. All central laboratories based in the US are obliged to meet clinical laboratory improvement amendment (CLIA) and state requirements. Additionally, US laboratories, as well as any medical laboratory that handles patient samples which originate in the US, can choose to comply with the requirements of the College of American Pathologists (CAP). In Europe, Asia and Australasia, laboratories will typically aim to comply with the standards published by the International Organization for Standardization (ISO), or with good laboratory practice (GLP) requirements.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Clare O'Sullivan, Laboratory Manager at ICON Laboratories

Clare O'Sullivan is the Laboratory Manager at ICON Laboratories, Europe. She holds a BSc (Hons) and a Masters degree in Microbiology from the National University of Ireland, Cork. Prior to becoming Laboratory Manager, Clare worked as QA Manager for over four years in ICON Laboratories and Tibotec-Virco Ireland, now a division of Johnson and Johnson. During her career as QA Manager she gained experience in the implementation and maintenance of quality systems compliant with ISO 17025, CAP, EN45001, EN45004 and CLIA regulations in both European and US-based facilities.

spacer
Clare O'Sullivan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement